Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in Patients With Subarachnoid Hemorrhage in the Intensive Care Unit (ICU.Delibma)

NCT07249619 is registered in ClinicalTrials.gov with Emre Şenocak as lead sponsor.

NCT NCT07249619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in Patients With Subarachnoid Hemorrhage in the Intensive Care Unit (ICU.Delibma)
Lead sponsor
Emre Şenocak
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 2, 2026
Completion date
January 2, 2028
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid haemorrhagic stroke